Álvaro H. Rodríguez C. MD, MSc
@ahrodrig
Followers
946
Following
1K
Media
308
Statuses
631
M. Internista-Cardiólogo-Ecocardiografista-Imagen cardiaca.NBE.Fellow SISIAC. Bioética. H. Cardiovascular de Cundinamarca-Cardio Colombia. Bogotá-Colombia.
Joined November 2010
65 y/o male, large thrombus in left atrial appendage, TEE prior to cardioversion.
1
9
53
Female 56 y/o. Stable angina;sudden death in 2019 during non-cardiac surgery, CDI implanted. Anomaly in the origin of the coronary arteries: no LMC,RCA arises from the RCS,LCX arises from the RCA and has a retroaortic course,LAD arises from the RCA with a trans-septal course.
1
5
13
82 y/o male, suspected mitral valve mass. TEE: calcium detritus, refers to small pieces or fragments of the calcified material that break away from the main MAC. These fragments can contribute to complications like: embolization, IE and increased surgical complexity.
0
0
1
75 y/o male. Stanford type A aortic dissection with severe RA. Coronary CT was performed to rule out coronary artery disease. Patient in surgery.
0
9
24
RT @MonicaSaadeX: 💥 🩺⚕️ATENCIÓN🇨🇴. Una médica colombiana le canta la tabla a Petro en solo 3 minutos, lo pone en su sitio, lo desenmascara….
0
3K
0
26 y/o female; PVS corrected with homograft at 6 years of age. Constitutional symptoms since 3 mo ago. Complex IE due to S. aureus involving the homograft (vegetations) with pseudoaneurysm ** (CT), mitral valve (pseudoaneurysm A1) and RA with mural vegetation. Critical condition.
1
4
21
66 y/o man referred for CMR for suspected noncompaction myocardium vs HCM. Cine 4 an distortion of LV wall architecture with muscular protrusions giving the impression of large crypts in the inferior and anterior septum 👆 and inferior wall 👇. SAW-TOOTH MYOCARDIUM.
0
0
2
56y/o male with a history of ischemic stroke. TEE floppy IAS with fenestrations (mfASDs). Qp:Qs = 1.68 : 1
0
7
27
Mitral and tricuspid myxomatous disease. NYHA II.
2
0
9
21 y/o male, change of AoV for mechanical prosthetic valve 2 y/o; non-therapeutic INR levels. HF NYHA II. Prosthetic dysfunction due to thrombus. Thrombolysis with alteplase (ultraslow infusion low-dose protocol) 25 mg for 25 hr). TTE after the first bolus with successful result.
3
8
23
62 y/o male, mass at the base of the posterior annulus of the tricuspid valve (ventricular side); echocardiographic and cardiac MRI features were benign; given its location, it is most likely CPF.
0
3
20
70 y/o male, IE-related pseudoaneurysm after Bentall surgery with vegetations and valvulitis in bioprostectic valve.
1
6
30
76 y/o male, history of CBAG and MVR by bioprosthetic valve 6 years ago; left heart failure NYHA III; normal gradients. Posterior and medial leak.
0
0
2
71 y/o male, left heart failure with reduced EF, pacing wires in right atrium with large thrombus.
1
10
36
77 y/o female, NYHA II. TTE HCM-MVO with apical aneurysm. Mild decreased EF; posterior and septal wall 24 mm
3
2
11
55 y/o female. Suspected PAD. TEE right coronary artery-pulmonary artery fistula.
2
11
26
69 y/o male. Acute severe MR secondary to ischemic papillary muscle rupture.
0
5
16
Ruptured aneurysmal dilatation of the noncoronary sinus of Valsalva. 18 y/o woman with symptoms of left heart failure.
0
3
7